Otras Soluciones
INTROS
Technical Description Laser Intros
- Shorter recovery times.
- Reduction of postoperative pain.
- Fewer local side effects on the sphincter and anal mucosa.
- Optimum esthetic results.
- Laser therapy is distinguished by its high level of safety and rapid healing process.
- The operation can be performed under local or short-term anesthesia.
Intros Infinity Hemorrhoids
- Stable fiber core diameter 600 μm.
- Coned quartz tip.
- Distal laser emission in 30º cone.
The pointed probe can be inserted into the hemorrhoidal pack to avoid leaving open wounds.
Intros Infinity Fistula
- Stable fiber core diameter 600 μm.
- Atraumatic rounded quartz tip.
- Homogeneous cylindrical emission 4mm.
The fistula probe provides easy access even in narrow and curved fistulas for permanent occlusion of anal fistulas.
References
ELUTAX3
Technical Description ELUTAX3 System
The Elutax 3 Central device is a drug-transporting balloon dilator used for the treatment of Fibrotic Stricture.
The Elitax 3 device is the only one that carries two drug agents:
- Paclitaxel, taxane, which is an antimicrotubule agent that inhibits cell proliferation preventing restenosis concentration of 2.2 μg paclitaxel/mm2.
- Dextran sulfate, which has an adhesive and binding effect on paclitaxel post dilatation, as well as an antithrombotic effect, concentration 0.7 μg Dextran/mm2.
It consists of 3 layers that allow the transport and permanence of the drug agents in the lesion to be treated:
- Ice layer: fixes the palitaxel to the balloon.
- Snow Coat: paclitaxel crystals.
- Gel layer: dextran protects paclitaxel transport, and fixes it to the internal part of the dilated duct.
Latex-free product.
References
The Matrix Patch™ Equine
Technical Description Laser Intros
The Matrix Patch™ Equine is a cell-free biological implant derived from equine pericardium, designed for the repair of congenital and acquired cardiac defects.
The tissue undergoes a proprietary glutaraldehyde-free decellularization and sterilization process, ensuring the complete removal of cellular components, DNA, and RNA. This process significantly reduces immunogenicity and eliminates the risk of pathogen transmission.
The result is a biocompatible, stable material with excellent mechanical properties, comparable to autologous pericardium and superior to glutaraldehyde-treated patches in terms of resistance to calcification and ease of handling.
Clinical Benefits
Reduced risk of calcification and tissue degeneration.
Improved intraoperative handling and suture precision.
High biological safety due to the absence of cellular material and glutaraldehyde.
Natural and durable integration with host tissue.
Proven clinical results: no calcification and excellent flexibility after 5 years of implantation (case report: Prof. Dr. Boulos Asfour, Deutsches Kinderherzzentrum).
References
